Phase I dose-escalation study of oral administration of MET Tyrosine Kinase Inhibitor S 49076 in patients with advanced solid tumours
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2017
At a glance
- Drugs S-49076 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man
- Sponsors Servier
- 01 Aug 2017 Results published in the European Journal of Cancer.
- 01 Nov 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 23 Oct 2013 Interim results presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History